China Pharma Holdings
CPHI
7 hedge funds and large institutions have $1.18M invested in China Pharma Holdings in 2013 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
31% more capital invested
Capital invested by funds: $902K → $1.18M (+$279K)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
22% less funds holding
Funds holding: 9 → 7 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
FWSM
First Wilshire Securities Management
Pasadena,
California
|
+$6.47K |
Top Sellers
CPHI Hedge Fund Activity: Q3 2013 in Review
7 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2013, worth a combined $1.18M — up 31% from $902K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was First Wilshire Securities Management, adding an estimated $6.47K. The largest seller was Straus Capital Management, cutting an estimated $20.6K.
- 7 institutional investors held China Pharma Holdings (CPHI) as of Q3 2013, down from 9 in Q2 2013.
- Funds reported $1.18M of China Pharma Holdings stock for Q3 2013, up 31% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q3 2013 and 3 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q3 2013 was First Wilshire Securities Management, an estimated $6.47K added.
- The largest China Pharma Holdings seller in Q3 2013 was Straus Capital Management, an estimated $20.6K sold.
Based on aggregated 13F filings for Q3 2013.